https://scholars.lib.ntu.edu.tw/handle/123456789/551621
標題: | Changing practice pattern of acute coronary syndromes in Taiwan from 2008 to 2015 | 作者: | Li Y.-H. Chiu Y.-W. Cheng J.-J. Hsieh I.-C. Lo P.-H. Lei M.-H. Ueng K.-C. FU-TIEN CHIANG Sung S.-H. Kuo J.-Y. Chen C.-P. Lai W.-T. Lee W.-L. Chen J.-H. |
關鍵字: | Acute coronary syndromes; Quality; Taiwan | 公開日期: | 2019 | 卷: | 35 | 期: | 1 | 起(迄)頁: | 1-10 | 來源出版物: | Acta Cardiologica Sinica | 摘要: | Background: Patients with acute coronary syndrome (ACS), including ST segment elevation myocardial infarction (STEMI) and non-ST segment elevation (NSTE)-ACS have a significant risk of morbidity and mortality. This study evaluated the practice patterns of ACS care in Taiwan from 2005 to 2018. Methods: Data from two nationwide ACS registries (2008-2010 and 2012-2015) were used. ACS patients who received percutaneous coronary interventions (PCIs) during admission were compared between the two registries. Results: In STEMI, the door-to-balloon time for primary PCI decreased by 25 min from a median of 96 to 71 min (p < 0.0001) from the first to second registry. More complex PCI procedures and drug-eluting stents were used for ACS. However, the onset-to-door time was still long for both STEMI and NSTE-ACS. The D2B time for NSTE-ACS was long, especially in the elderly and female patients. Although the prescription rate of secondary preventive medications for ACS increased, it was still relatively low compared with Western data, especially in NSTE-ACS. Conclusions: The registry data showed that ACS care quality has improved in Taiwan. However, areas including onset-to-door time and use of secondary preventive medications still need further improvements. ? 2019, Republic of China Society of Cardiology. All rights reserved. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/551621 | ISSN: | 1011-6842 | DOI: | 10.6515/ACS.201901_35(1).20180716B | SDG/關鍵字: | acetylsalicylic acid; angiotensin receptor antagonist; antithrombocytic agent; beta adrenergic receptor blocking agent; biological marker; calcium channel blocking agent; cholinesterase inhibitor; clopidogrel; creatine kinase; creatinine; heparin; hydroxymethylglutaryl coenzyme A reductase inhibitor; nitrate; troponin; acute coronary syndrome; adult; aged; Article; atrial fibrillation; cardiovascular risk; comparative study; coronary artery bypass graft; door-to-balloon time; electrocardiography; female; heart failure; hospital admission; hospitalization; human; major clinical study; male; medical parameters; mortality rate; onset-to-door time; percutaneous coronary intervention; ST segment elevation myocardial infarction; time to treatment |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。